Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Graft vs Host Disease

n(g),n(g')-dimethyl-l-arginine has been researched along with Graft vs Host Disease in 1 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Radujkovic, A1
Dai, H1
Kordelas, L1
Beelen, D1
Rachakonda, SP1
Müller-Tidow, C1
Kumar, R1
Dreger, P1
Luft, T1

Trials

1 trial available for n(g),n(g')-dimethyl-l-arginine and Graft vs Host Disease

ArticleYear
Asymmetric dimethylarginine serum levels are associated with early mortality after allogeneic stem cell transplantation.
    Haematologica, 2019, Volume: 104, Issue:4

    Topics: Allografts; Arginine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell

2019